234 related articles for article (PubMed ID: 27166381)
21. Proteinuria and Reduced Estimated Glomerular Filtration Rate Are Independent Risk Factors for Contrast-Induced Nephropathy After Cardiac Catheterization.
Saito Y; Watanabe M; Aonuma K; Hirayama A; Tamaki N; Tsutsui H; Murohara T; Ogawa H; Akasaka T; Yoshimura M; Sato A; Takayama T; Sakakibara M; Suzuki S; Ishigami K; Onoue K;
Circ J; 2015; 79(7):1624-30. PubMed ID: 25891891
[TBL] [Abstract][Full Text] [Related]
22. Evidence for shrunken pore syndrome in children.
den Bakker E; Gemke RJ; van Wijk JA; Hubeek I; Stoffel-Wagner B; Bökenkamp A
Scand J Clin Lab Invest; 2020 Feb; 80(1):32-38. PubMed ID: 31755786
[TBL] [Abstract][Full Text] [Related]
23. Insulin Resistance Increases the Risk of Contrast-Induced Nephropathy in Patients Undergoing Elective Coronary Intervention.
Li Y; Liu Y; Shi D; Yang L; Liang J; Zhou Y
Angiology; 2016 Feb; 67(2):139-45. PubMed ID: 25843952
[TBL] [Abstract][Full Text] [Related]
24. Contrast volume to estimated glomerular filtration rate ratio for prediction of contrast-induced acute kidney injury after cardiac catheterization in adults with congenital heart disease.
Gellis L; Gauvreau K; Ferguson M; Bergersen L; Shafer K; Porras D
Catheter Cardiovasc Interv; 2018 Dec; 92(7):1301-1308. PubMed ID: 30196559
[TBL] [Abstract][Full Text] [Related]
25. Safe contrast volumes for preventing contrast-induced nephropathy in elderly patients with relatively normal renal function during percutaneous coronary intervention.
Liu Y; Liu YH; Chen JY; Tan N; Zhou YL; Duan CY; Yu DQ; Xie NJ; Li HL; Chen PY
Medicine (Baltimore); 2015 Mar; 94(12):e615. PubMed ID: 25816028
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
[TBL] [Abstract][Full Text] [Related]
27. A head-to-head comparison of homocysteine and cystatin C as pre-procedure predictors for contrast-induced nephropathy in patients undergoing coronary computed tomography angiography.
Li S; Tang X; Peng L; Luo Y; Zhao Y; Chen L; Dong R; Zhu J; Chen Y; Liu J
Clin Chim Acta; 2015 Apr; 444():86-91. PubMed ID: 25687162
[TBL] [Abstract][Full Text] [Related]
28. Cystatin C-based eGFR is a superior prognostic parameter to creatinine-based eGFR in post-endovascular therapy peripheral artery disease patients.
Otaki Y; Takahashi H; Watanabe T; Yamaura G; Funayama A; Arimoto T; Shishido T; Miyamoto T; Kubota I
Circ J; 2015; 79(11):2480-6. PubMed ID: 26354502
[TBL] [Abstract][Full Text] [Related]
29. The influence of contrast media on kidney function in patients with stable coronary artery disease.
Reuter SB; Harutyunyan M; Mygind ND; Jørgensen E; Kastrup J
Scand Cardiovasc J; 2014 Aug; 48(4):234-40. PubMed ID: 24941300
[TBL] [Abstract][Full Text] [Related]
30. Prediction of contrast-induced nephropathy by the serum creatinine level on the day following cardiac catheterization.
Watanabe M; Saito Y; Aonuma K; Hirayama A; Tamaki N; Tsutsui H; Murohara T; Ogawa H; Akasaka T; Yoshimura M; Sato A; Takayama T; Sakakibara M; Suzuki S; Ishigami K; Onoue K;
J Cardiol; 2016 Nov; 68(5):412-418. PubMed ID: 26708123
[TBL] [Abstract][Full Text] [Related]
31. Elevated serum cystatin C level is an independent predictor of contrast-induced nephropathy and adverse outcomes in patients with peripheral artery disease undergoing endovascular therapy.
Kim GS; Ko YG; Shin DH; Kim JS; Kim BK; Choi D; Hong MK; Jang Y
J Vasc Surg; 2015 May; 61(5):1223-30. PubMed ID: 25595408
[TBL] [Abstract][Full Text] [Related]
32. Effect of N-acetylcysteine on cystatin C-based renal function after elective coronary angiography (ENABLE Study): a prospective, randomized trial.
Kim BJ; Sung KC; Kim BS; Kang JH; Lee KB; Kim H; Lee MH
Int J Cardiol; 2010 Feb; 138(3):239-45. PubMed ID: 18793808
[TBL] [Abstract][Full Text] [Related]
33. N-acetylcysteine in preventing contrast-induced nephropathy assessed by cystatin C.
Alioglu E; Saygi S; Turk U; Kirilmaz B; Tuzun N; Duman C; Tengiz I; Yildiz S; Ercan E
Cardiovasc Ther; 2013 Jun; 31(3):168-73. PubMed ID: 22212518
[TBL] [Abstract][Full Text] [Related]
34. Predictive Value of Gamma-Glutamyl Transferase Levels for Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention.
Oksuz F; Yarlioglues M; Cay S; Celik IE; Mendi MA; Kurtul A; Cankurt T; Kuyumcu S; Canpolat U; Turak O
Am J Cardiol; 2015 Sep; 116(5):711-6. PubMed ID: 26116992
[TBL] [Abstract][Full Text] [Related]
35. Effect of Alprostadil on the Prevention of Contrast-Induced Nephropathy: A Meta-Analysis of 36 Randomized Controlled Trials.
Xie J; Jiang M; Lin Y; Deng H; Li L
Angiology; 2019 Aug; 70(7):594-612. PubMed ID: 30669852
[TBL] [Abstract][Full Text] [Related]
36. Administration of contrast media just before cisplatin-based chemotherapy increases cisplatin-induced nephrotoxicity.
Sendur MA; Aksoy S; Yaman S; Arik Z; Tugba Kos F; Akinci MB; Civelek B; Yildirim Ozdemir N; Uncu D; Zengin N
J BUON; 2013; 18(1):274-80. PubMed ID: 23613416
[TBL] [Abstract][Full Text] [Related]
37. Utility of estimated glomerular filtration rate using cystatin C and its interpretation in patients with rheumatoid arthritis under glucocorticoid therapy.
Nozawa Y; Sato H; Wakamatsu A; Kobayashi D; Nakatsue T; Wada Y; Kuroda T; Kazama JJ; Suzuki Y; Nakano M; Narita I
Clin Chim Acta; 2018 Dec; 487():299-305. PubMed ID: 30321524
[TBL] [Abstract][Full Text] [Related]
38. The ratio of contrast medium volume to estimated glomerular filtration rate as a predictor of contrast-induced nephropathy after endovascular aortic repair.
Kawatani Y; Kurobe H; Nakamura Y; Hori T; Kitagawa T
J Med Invest; 2018; 65(1.2):116-121. PubMed ID: 29593180
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of different laboratory measures of renal function for long-term mortality after contrast media-associated renal impairment.
Heitmeyer C; Hölscher B; Fobker M; Breithardt G; Hausberg M; Reinecke H
Clin Cardiol; 2010 Dec; 33(12):E51-9. PubMed ID: 21184545
[TBL] [Abstract][Full Text] [Related]
40. Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients.
Sany D; Refaat H; Elshahawy Y; Mohab A; Ezzat H
Ren Fail; 2014 Mar; 36(2):191-7. PubMed ID: 24138570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
